Patient free text reporting of symptomatic adverse events in cancer clinical research using the National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

被引:55
|
作者
Chung, Arlene E. [1 ,2 ,3 ]
Shoenbill, Kimberly [2 ,4 ]
Mitchell, Sandra A. [5 ]
Dueck, Amylou C. [6 ]
Schrag, Deborah [7 ]
Bruner, Deborah W. [8 ]
Minasian, Lori M. [5 ]
St Germain, Diane [5 ]
O'Mara, Ann M. [5 ]
Baumgartner, Paul [9 ]
Rogak, Lauren J. [10 ]
Abernethy, Amy P. [11 ,12 ]
Griffin, Ashley C. [2 ]
Basch, Ethan M. [1 ,2 ,3 ,10 ]
机构
[1] Univ N Carolina, Sch Med, Dept Med, Chapel Hill, NC 27515 USA
[2] Univ N Carolina, Sch Med, Program Hlth & Clin Informat, Chapel Hill, NC 27515 USA
[3] Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27515 USA
[4] Univ N Carolina, Sch Med, Dept Family Med, Chapel Hill, NC 27515 USA
[5] NCI, Rockville, MD USA
[6] Mayo Clin, Alliance Stat & Data Ctr, Scottsdale, AZ USA
[7] Dana Farber Harvard Canc Ctr, Div Populat Sci, Dept Med Oncol, Brookline, MA USA
[8] Emory Univ, Nell Hodgson Woodruff Sch Nursing, Winship Canc Inst, Atlanta, GA 30322 USA
[9] Semant Bits LLC, Herndon, VA USA
[10] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, 1275 York Ave, New York, NY 10021 USA
[11] Duke Canc Inst, Dept Med, Durham, NC USA
[12] Flatiron Hlth, New York, NY USA
基金
美国国家卫生研究院;
关键词
PRO-CTCAE; patient-reported outcomes; free text; symptomatic adverse events; MedDRA; ELECTRONIC HEALTH RECORDS; DRUG EVENTS;
D O I
10.1093/jamia/ocy169
中图分类号
TP [自动化技术、计算机技术];
学科分类号
0812 ;
摘要
Objective The study sought to describe patient-entered supplemental information on symptomatic adverse events (AEs) in cancer clinical research reported via a National Cancer Institute software system and examine the feasibility of mapping these entries to established terminologies. Materials and Methods Patients in 3 multicenter trials electronically completed surveys during cancer treatment. Each survey included a prespecified subset of items from the National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). Upon completion of the survey items, patients could add supplemental symptomatic AE information in a free text box. As patients typed into the box, structured dropdown terms could be selected from the PRO-CTCAE item library or Medical Dictionary for Regulatory Activities (MedDRA), or patients could type unstructured free text for submission. Results Data were pooled from 1760 participants (48% women; 78% White) who completed 8892 surveys, of which 2387 (26.8%) included supplemental symptomatic AE information. Overall, 1024 (58%) patients entered supplemental information at least once, with an average of 2.3 per patient per study. This encompassed 1474 of 8892 (16.6%) dropdowns and 913 of 8892 (10.3%) unstructured free text entries. One-third of the unstructured free text entries (32%) could be mapped post hoc to a PRO-CTCAE term and 68% to a MedDRA term. Discussion Participants frequently added supplemental information beyond study-specific survey items. Almost half selected a structured dropdown term, although many opted to submit unstructured free text entries. Most free text entries could be mapped post hoc to PRO-CTCAE or MedDRA terms, suggesting opportunities to enhance the system to perform real-time mapping for AE reporting. Conclusions Patient reporting of symptomatic AEs using a text box functionality with mapping to existing terminologies is both feasible and informative.
引用
收藏
页码:276 / 285
页数:10
相关论文
共 50 条
  • [21] Japanese translation and linguistic validation of the us national cancer institute’s patient-reported outcomes version of the common terminology criteria for adverse events (Pro-ctcae)
    Miyaji T.
    Iioka Y.
    Kuroda Y.
    Yamamoto D.
    Iwase S.
    Goto Y.
    Tsuboi M.
    Odagiri H.
    Tsubota Y.
    Kawaguchi T.
    Sakata N.
    Basch E.
    Yamaguchi T.
    Journal of Patient-Reported Outcomes, 1 (1)
  • [22] Linguistic validation of the simplified Chinese version of the US National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE™)
    Cheng, K. K. F.
    Mitchell, S. A.
    Chan, N.
    Ang, E.
    Tam, W.
    Kanesvaran, R.
    BMC CANCER, 2020, 20 (01)
  • [23] Danish Translation and Linguistic Validation of the US National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
    Baeksted, Christina
    Nissen, Aase
    Pappot, Helle
    Bidstrup, Pernille Envold
    Mitchell, Sandra A.
    Basch, Ethan
    Dalton, Susanne Oksbjerg
    Johansen, Christoffer
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2016, 52 (02) : 292 - 297
  • [24] Dutch translation and linguistic validation of the US National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE™)
    Veldhuijzen, Evalien
    Walraven, Iris
    Mitchell, Sandra A.
    Moore, Elizabeth Yohe
    McKown, Shawn M.
    Lauritzen, Matthew
    Kim, Katherine J.
    Belderbos, Jose S. A.
    Aaronson, Neil K.
    JOURNAL OF PATIENT-REPORTED OUTCOMES, 2020, 4 (01)
  • [25] Dutch translation and linguistic validation of the US National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
    Veldhuijzen, Aaltje E.
    Belderbos, Jose S. A.
    Mitchell, Sandra A.
    McKown, Shawn M.
    Lauritzen, Matthew
    Moore, Elizabeth Yohe
    Kim, Katherine J.
    Walraven, His
    Aaronson, Neil K.
    QUALITY OF LIFE RESEARCH, 2018, 27 : S67 - S68
  • [26] Feasibility of Patient Reporting of Symptomatic Adverse Events via the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in a Chemoradiotherapy Cooperative Group Multicenter Clinical Trial
    Basch, Ethan
    Pugh, Stephanie L.
    Dueck, Amylou C.
    Mitchell, Sandra A.
    Berk, Lawrence
    Fogh, Shannon
    Rogak, Lauren J.
    Gatewood, Marcha
    Reeve, Bryce B.
    Mendoza, Tito R.
    O'Mara, Ann M.
    Denicoff, Andrea M.
    Minasian, Lori M.
    Bennett, Antonia V.
    Setser, Ann
    Schrag, Deborah
    Roof, Kevin
    Moore, Joan K.
    Gergel, Thomas
    Stephans, Kevin
    Rimner, Andreas
    DeNittis, Albert
    Bruner, Deborah Watkins
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 98 (02): : 409 - 418
  • [27] Methodological standards for using the patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE) in cancer clinical trials Comment
    Basch, Ethan
    Thanarajasingam, Gita
    Dueck, Amylou C.
    CLINICAL TRIALS, 2022, 19 (03) : 274 - 276
  • [28] Psychometric validity of the Japanese version of Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
    Azuma, Kanako
    Kawaguchi, Takashi
    Miyaji, Tempei
    Sano, Motohiko
    Kim, Soan
    Kawahara, Yosuke
    Torii, Ayako
    Yamada, Yuri
    Hirata, Taiki
    Ishibashi, Keiichiro
    Okubo, Atsushi
    Basch, Ethan
    Yamaguchi, Takuhiro
    QUALITY OF LIFE RESEARCH, 2017, 26 (01) : 100 - 101
  • [29] Translation and linguistic validation of the US National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE™) in 10 languages
    Mitchell, Sandra
    Moore, Elizabeth Yohe
    McKown, Shawn
    Poepsel, Timothy
    Lauritzen, Matthew
    Campbell, Alicyn
    Piault, Elisabeth
    Zarzar, Katherine
    Kim, Katherine
    QUALITY OF LIFE RESEARCH, 2018, 27 : S25 - S25
  • [30] Dutch translation and linguistic validation of the U.S. National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE™)
    Evalien Veldhuijzen
    Iris Walraven
    Sandra A. Mitchell
    Elizabeth Yohe Moore
    Shawn M. McKown
    Matthew Lauritzen
    Katherine J. Kim
    José S. A. Belderbos
    Neil K. Aaronson
    Journal of Patient-Reported Outcomes, 4